1. Hanley K, O’Dowd T. Symptoms of vertigo in general practice:
a prospective study of diagnosis. Br J Gen Pract 2002;52:809-12.
2. Kroenke K, Lucas CA, Rosenberg ML, et al. Causes of
persistent dizziness. A prospective study of 100 patients in
ambulatory care. Ann Intern Med 1992;117:898-904.
3. Maarsingh OR, Dros J, Schellevis FG, et al. Causes of Persistent
Dizziness in Elderly Patients in Primary Care. Ann Fam Med
2010; 8(3):196-205.
Bayındır ve ark.
162
4. Akyıldız N. Kulak Hastalıkları ve Mikrocerrahisi. 1st edition Cilt
I. Ankara: Bilimsel Tıp Yayınevi, 1998:103-129.
5. Moulin T, Sablot D, Vidry E, et al. Impact of emergency room
neurologists on patient management and outcome. Eur Neurol
2003;50:207-214.
6. Labuguen RH, Initial Evaluation of Vertigo. Am Fam Physician
2006;73:244-51.
7. Korkut N. Vertigoya genel bakış. Klinik Gelişim 2005;18(1):65-
72.
8. Buttner U, Helmchen C, Brandt T. Diagnostic criteria for
central versus peripheral positioning nystagmus and vertigo: a
review. Acta Otolaryngol 1999;119:1-5.
9. Baloh RW. Differentiating between peripheral and central
causes of vertigo. Otolaryngol Head Neck Surg 1998;119:55-9.
10. Derebery MJ. The diagnosis and treatment of dizziness. Med
Clin North Am 1999;83:163-77.
11. Rosenberg ML, Gizzi M. Neuro-otologic history. Otolaryngol
Clin North Am 2000;33:471-82.
12. Drachman DA. A 69-year-old man with chronic dizziness
[published correction appears in JAMA 1999;281:899]. JAMA
1998;280:2111-8.
13. Cass SP, Furman JM, Ankerstjerne K, Balaban C, Yetiser S,
Aydogan B. Migraine-related vestibulopathy. Ann Otol Rhinol
Laryngol 1997;106:182-9.
14. Akkuzu G, Akkuzu B, Ozluoglu LN. Vestibular evoked
myogenic potentials in benign paroxysmal positional vertigo and
Meniere’s disease. Eur Arch Otorhinolaryngol 2006;263:510-7.
15. Aydin E, Akman K, Yerli H, et al. Benign paroxysmal positional
vertigo after radiologic scanning: a case series. J Med Case
Reports 2008;2:92
16. Dix R, Hallpike CS. The pathology, symptomatology, and
diagnosis of certain common disorders of the vestibular system.
Ann Otol Rhinol Laryngol 1952;6:987-1016.
17. Katsarkas A. Benign paroxysmal positional vertigo (BPPV):
idiopathic versus post-traumatic. Acta Otolaryngol
1999;119:745-9.
18. Özlüoğlu LN, Akkuzu B, Dal T, et al. Etiological factors in
benign paroxsymal positional vertigo and effects on results of
canalith repositioning manevour. Politzer Society-International
Society for Otological Surgery XXI. Annual Meeting, 1998,
Antalya.
19. Schuknecht HF. Cupulolithiasis. Arch Otolaryngol 1969;90:765-
78.
20. Hall SF, Ruby RR, McClure JA. The mechanics of benign
paroxysmal vertigo. J Otolaryngol 1979;8:151-8.
21. Epley JM. Positional vertigo related to semicircular canalithiasis.
Otolaryngol Head Neck Surg 1995;112:154-61.
22. Epley JM. Particle repositioning for benign paroxsymal
positional vertigo. Otolaryngol Clin North Am 1996;29:323-31.
23. Epley JM. The canalith repositioning procedure: for treatment
of benign paroxysmal positional vertigo. Otolaryngol Head
Neck Surg 1992;107:399-404.
24. Ruckenstein MJ. Therapeutic efficacy of the Epley canalith
repositioning maneuver. Laryngoscope 2001;111:940-5.
25. Ozturan O, Cokkeser Y, Saydam L, et al. Benign Paroksismal
Pozisyonel Vertigo ve Kanalit Repozisyon Prosedürü. Kulak
Burun Boğaz İhtis Derg 1998;5:16-21.
26. Humphriss RL, Baguley DM, Sparkes V, et al. Contraindications
to the Dix-Hallpike manoeuvre: a multidisciplinary review. Int J
Audiol 2003;42:166-73.
27. Smouha EE. Time course of recovery after Epley manoeuvres
for benign paroxysmal positional vertigo. Laryngoscope
1997;107:187-91.
28. Dal T, Ozluoglu LN, Ergin NT. The canalith repositioning
maneuver in patients with benign positional vertigo. Eur Arch
Otorhinolaryngol 2000;257:133-6.
29. Nunez RA, Cass SP, Furman JM. Short- and long-term
outcomes of canalith repositioning for benign paroxysmal
positional vertigo. Otolaryngol Head Neck Surg 2000;122: 647-
52.
30. Helminski JO, Janssen I, Kotaspouikis D, et al. Strategies to
prevent recurrence of benign paroxysmal positional vertigo.
Arch Otolaryngol Head Neck Surg 2005;131:344-8.
31. Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, et al. Longterm
outcome and health-related quality of life in benign
paroxysmal positional vertigo. Eur Arch Otorhinolaryngol
2005;262:507-11.
32. Rashad UM. Long-term follow up after Epley’s maneuvers in
patients with benign paroxysmal positional vertigo. J Laryngol
Otol 2009;123:69-74.
33. Sakaida M, Takeuchi K, Ishinaga H, et al. Long-term outcome
of benign paroxysmal positional vertigo. Neurology
2003;60:1532-4.
34. Brandt T, Huppert D, Hecht J, et al. Benign paroxysmal
positioning vertigo: a long-term follow-up (6-17 years) of 125
patients. Acta Otolaryngol 2006;126:160-3
35. Yetişer S, Birkent H. Vestibüler bozukluklar. In: Lalwani AK
Editör; Cingi C Çeviri editörü. Lange Current
Otorinolaringoloji-Baş ve Boyun Cerrahisi Tanı ve Tedavi. 1st
ed. Ankara, Güneş Kitabevi. 2005. p. 761-70.
36. da Costa SS,de Sousa LC, Piza MR. Meniere’s disease :
Overview, epidemiology, and natural history. Otolaryngol Clin
North Am 2002;35:455-95.
37. Li JC (2009) Inner ear, Ménière disease, medical treatment.
Available via dialog.
http://emedicine.medscape.com/article/856547-overview.
Accessed 2009;28.
38. Gürsel B, Özer F. Meniere Hastalığı. In: Koç C (ed); Kulak
Burun Boğaz Hastalıkları ve Baş Boyun Cerrahisi. 1st ed.
Ankara, Güneş Kitabevi 2004. p. 305-12.
39. Saeed SR, Fortnightly review: Diagnosis and treatment of
Meniere’s disease. BMJ 1998;316:368-72.
40. Coelho DH, Lalwani AK. Medical management of Ménière’s
disease. Laryngoscope 2008;118:1099-1106
41. Brookes GB. The Pharmacological treatment of Meniere’s
disease. Clin Otolaryngol 1996;21:3-11.
42. Hellström S, Odkvist L. Pharmacologic labyrinthectomy.
Otolaryngol Clin North Am 1994;27:307-15.
43. Bodmer D, Morong S, Stewart C, et al. Long-term vertigo
control in patients after intratympanic gentamicin instillation for
Ménière’s disease. Otol Neurotol 2007;28:1140-4.
44. Nedzelski JM, Schessel DA, Bryce GE, et al. Chemical
labyrinthectomy: local application of gentamicin for the
treatment of unilateral Meniere’s disease. Am J Otol 1992;13;18-
22.
45. Akkuzu B, Ozgirgin N, Ozluoglu LN. Meniere hastalığında
intratimpanik tedavi: Gentamisin ve deksametazonun vertigo
kontrolü ve işitme üzerine etkisi. Kulak Burun Boğaz Ihtis Derg
2006:1693-9.
46. Goksu N, Beyazıt YA, Yilmaz M, et al. Surgical treatment of
peripheral vertigo and vertiginous diseases. ORL 2005:67:1-9.
47. Goksu N, Betazıt Y, Beder L. Posterior fossa vestibular nerve
section for the management of peripheral vertigo. Eur Arch
Otorhinolaryngol 1999; 256:230-2.
48. Akyıldız N. Kulak Hastalıkları ve Mikrocerrahisi. 1st edition Cilt
II. Ankara: Bilimsel Tıp Yayınevi, 1998 p.109-150.
49. Hotson JR, Baloh RW. Acute vestibular syndrome. N Engl J
Med 1998;339(10):680-5.
50. Ariyasu L, Byl FM, Sprague MS, et al. The beneficial effect of
methylprednisolone in acute vestibular vertigo. Arch
Otolaryngol Head Neck Surg 1990;116:700-3.
Periferik Vertigo
163
51. Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone,
valacyclovir, or the combination for vestibular neuritis. N Engl J
Med 2004;351(4):354-61.
52. Ohbayashi S, Oda M, Yamamoto M, et al. Recovery of the
vestibular function after vestibular neuronitis. Acta Otolaryngol
Suppl 1993;503:31-4.
53. Clendaniel RA, Helminaski JO. Rehabilitation strategies for
patients with vestibular deficits. In: Arenberg LK (ed).
Dizzeness and balance disorders. New York:Kugler
Publications, 1993:663-75.
54. Tee LH, Chee NW. Vestibular rehabilitation therapy. Ann Acad
Med Singapore 2005;34:289-94.
55. Hain TC. Balance and vestibular rehabilitation therapy.
Available from
URL:http//www.tchain.com/otoneurology/treatment/rehab.
Thank you for copying data from http://www.arastirmax.com
